Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Keratosis, Actinic 2Bowen's Disease 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 900Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × SR-T100 × Clear all
NCT01516515 2018-12-05

Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis

G&E Herbal Biotechnology Co., LTD

Phase 2 Completed
86 enrolled
Dermatologic

Keratosis, Actinic

NCT02085395 2014-03-14

AK

G&E Herbal Biotechnology Co., LTD

Phase 2 Completed
27 enrolled
Dermatologic

Bowen's Disease, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡